Switch theme
Sign up to access all valuation multiples
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
2014
5.5K+
LTM Revenue $1.9B
LTM EBITDA $432M
$1.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Curaleaf has a last 12-month revenue of $1.9B and a last 12-month EBITDA of $432M.
In the most recent fiscal year, Curaleaf achieved revenue of $939M and an EBITDA of $163M.
Curaleaf expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Curaleaf valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $942M | $939M | XXX | XXX | XXX |
| Gross Profit | $405M | $430M | XXX | XXX | XXX |
| Gross Margin | 43% | 46% | XXX | XXX | XXX |
| EBITDA | $131M | $163M | XXX | XXX | XXX |
| EBITDA Margin | 14% | 17% | XXX | XXX | XXX |
| Net Profit | -$259M | -$197M | XXX | XXX | XXX |
| Net Margin | -27% | -21% | XXX | XXX | XXX |
| Net Debt | $322M | $347M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Curaleaf's stock price is CAD 1 (or $1).
Curaleaf has current market cap of CAD 838M (or $586M), and EV of CAD 1.9B (or $1.3B).
See Curaleaf trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.3B | $586M | XXX | XXX | XXX | XXX | $-0.26 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Curaleaf has market cap of $586M and EV of $1.3B.
Curaleaf's trades at 1.0x LTM EV/Revenue multiple, and 4.4x LTM EBITDA.
Analysts estimate Curaleaf's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Curaleaf and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.3B | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | 8.1x | XXX | XXX | XXX |
| P/E | -3.9x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 29.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpCuraleaf's NTM/LTM revenue growth is -1%
Curaleaf's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Curaleaf's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Curaleaf's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Curaleaf and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 0% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 24% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 16% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 30% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 46% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Ascend Wellness Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Ayr Wellness | XXX | XXX | XXX | XXX | XXX | XXX |
| Cresco Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Grown Rogue | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Curaleaf acquired XXX companies to date.
Last acquisition by Curaleaf was XXXXXXXX, XXXXX XXXXX XXXXXX . Curaleaf acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Curaleaf founded? | Curaleaf was founded in 2014. |
| Where is Curaleaf headquartered? | Curaleaf is headquartered in Canada. |
| How many employees does Curaleaf have? | As of today, Curaleaf has 5.5K+ employees. |
| Who is the CEO of Curaleaf? | Curaleaf's CEO is Mr. Boris Jordan. |
| Is Curaleaf publicy listed? | Yes, Curaleaf is a public company listed on TSE. |
| What is the stock symbol of Curaleaf? | Curaleaf trades under CURA ticker. |
| When did Curaleaf go public? | Curaleaf went public in 2015. |
| Who are competitors of Curaleaf? | Similar companies to Curaleaf include e.g. Live Verdure, Ascend Wellness Holdings, Ayr Wellness, Cresco Labs. |
| What is the current market cap of Curaleaf? | Curaleaf's current market cap is $586M |
| What is the current revenue of Curaleaf? | Curaleaf's last 12-month revenue is $1.9B. |
| What is the current EBITDA of Curaleaf? | Curaleaf's last 12-month EBITDA is $432M. |
| What is the current EV/Revenue multiple of Curaleaf? | Current revenue multiple of Curaleaf is 1.0x. |
| What is the current EV/EBITDA multiple of Curaleaf? | Current EBITDA multiple of Curaleaf is 4.4x. |
| What is the current revenue growth of Curaleaf? | Curaleaf revenue growth between 2023 and 2024 was 0%. |
| Is Curaleaf profitable? | Yes, Curaleaf is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
